X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-05 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $2.22 | -36,248 | 2,731,624 | -1% | -$80,503 | ||||||
2023-11-20 | VRNA | Edwards Martin | Dir | P - Purchase | $1.84 | +33,736 | 144,800 | +30% | +$61,973 | ||||||
2023-11-06 | VRNA | Ebsworth David R | Dir | P - Purchase | $1.98 | +160,000 | 844,643 | +23% | +$316,080 | ||||||
2023-11-03 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $1.92 | -58,752 | 2,840,640 | -2% | -$112,804 | ||||||
| M | 2023-08-03 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $2.53 | -80,144 | 2,872,528 | -3% | -$202,576 | |||||
| M | 2023-08-03 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $2.52 | -275,888 | 16,431,800 | -2% | -$693,897 | |||||
| M | 2023-08-03 | VRNA | Hahn Mark W | CFO | S - Sale | $2.52 | -275,888 | 15,521,248 | -2% | -$693,897 | |||||
| M | 2023-08-03 | VRNA | Poll Claire | GC | S - Sale | $2.52 | -48,472 | 2,681,623 | -2% | -$121,914 | |||||
| M | 2023-08-01 | VRNA | Hahn Mark W | CFO | S - Sale | $2.64 | -179,648 | 15,797,136 | -1% | -$474,938 | |||||
| M | 2023-08-01 | VRNA | Poll Claire | GC | S - Sale | $2.64 | -31,552 | 2,730,095 | -1% | -$83,415 | |||||
| M | 2023-08-01 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $2.64 | -179,648 | 16,707,688 | -1% | -$474,938 | |||||
| M | 2023-08-01 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $2.64 | -33,464 | 2,952,672 | -1% | -$88,469 | |||||
| M | 2023-05-11 | VRNA | Orbimed Advisors LLC | Dir | S - Sale | $20.58 | -482,913 | 3,777,778 | -11% | -$9,938,132 | |||||
| M | 2023-05-11 | VRNA | Gupta Rishi | Dir | S - Sale | $20.58 | -482,913 | 3,777,778 | -11% | -$9,938,132 | |||||
2023-05-01 | VRNA | Poll Claire | GC | S - Sale | $2.58 | -80,376 | 2,753,319 | -3% | -$207,041 | ||||||
| M | 2023-05-01 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $2.60 | -106,176 | 2,971,136 | -3% | -$275,678 | |||||
2023-05-01 | VRNA | Hahn Mark W | CFO | S - Sale | $2.58 | -455,528 | 15,976,784 | -3% | -$1,173,395 | ||||||
2023-05-01 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $2.58 | -455,536 | 16,887,336 | -3% | -$1,173,415 | ||||||
2023-02-01 | VRNA | Hahn Mark W | CFO | S - Sale | $2.56 | -413,168 | 16,432,312 | -2% | -$1,056,553 | ||||||
2023-02-01 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $2.56 | -432,928 | 17,342,872 | -2% | -$1,107,083 | ||||||
| DM | 2023-02-01 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale+OE | $2.55 | -118,712 | 3,077,312 | -4% | -$302,731 | |||||
| D | 2023-02-01 | VRNA | Poll Claire | GC | S - Sale+OE | $2.59 | -152,000 | 2,833,695 | -5% | -$394,273 | |||||
2022-12-22 | VRNA | Poll Claire | GC | S - Sale | $2.69 | -240,000 | 2,806,895 | -8% | -$646,032 | ||||||
| M | 2022-12-22 | VRNA | Orbimed Advisors LLC | Dir | S - Sale | $22.15 | -6,139,864 | 34,085,528 | -15% | -$136,000,855 | |||||
| M | 2022-12-22 | VRNA | Gupta Rishi | Dir | S - Sale | $22.15 | -6,139,864 | 34,085,528 | -15% | -$136,000,855 | |||||
2022-12-20 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $2.12 | -600,000 | 17,775,800 | -3% | -$1,269,600 | ||||||
2022-12-20 | VRNA | Hahn Mark W | CFO | S - Sale | $2.12 | -600,000 | 16,845,480 | -3% | -$1,269,060 | ||||||
2022-11-01 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $1.67 | -32,904 | 18,375,800 | 0% | -$55,035 | ||||||
2022-11-01 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $1.64 | -28,752 | 3,091,024 | -1% | -$47,125 | ||||||
2022-11-01 | VRNA | Hahn Mark W | CFO | S - Sale | $1.67 | -13,160 | 17,445,480 | 0% | -$22,011 | ||||||
2022-08-15 | VRNA | Access Industries Holdings LLC | 10% | P - Purchase | $1.31 | +4,800,000 | 55,911,648 | +9% | +$6,300,000 | ||||||
2022-08-09 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $1.75 | -600,000 | 15,263,560 | -4% | -$1,050,000 | ||||||
2022-08-09 | VRNA | Hahn Mark W | CFO | S - Sale | $1.75 | -600,000 | 14,313,496 | -4% | -$1,050,000 | ||||||
2022-08-01 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $0.70 | -32,904 | 15,863,560 | 0% | -$23,026 | ||||||
2022-08-02 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $0.70 | -28,752 | 2,376,040 | -1% | -$20,216 | ||||||
2022-08-01 | VRNA | Hahn Mark W | CFO | S - Sale | $0.70 | -13,168 | 14,913,496 | 0% | -$9,215 | ||||||
2022-05-03 | VRNA | Zaccardelli David | Pres, CEO | S - Sale | $0.50 | -32,904 | 16,351,328 | 0% | -$16,307 | ||||||
2022-05-03 | VRNA | Rickard Kathleen A. | Chief Medical Officer | S - Sale | $0.49 | -28,752 | 2,461,224 | -1% | -$14,155 | ||||||
2022-05-03 | VRNA | Hahn Mark W | CFO | S - Sale | $0.50 | -12,512 | 15,381,520 | 0% | -$6,201 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |